NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,707,377 | +3.2% | 203,293 | +2.3% | 0.08% | +5.1% |
Q2 2023 | $20,057,732 | +16.1% | 198,769 | +5.8% | 0.08% | +11.3% |
Q1 2023 | $17,277,005 | +1.6% | 187,794 | +0.2% | 0.07% | -4.1% |
Q4 2022 | $17,000,153 | +21.0% | 187,391 | +1.4% | 0.07% | +12.1% |
Q3 2022 | $14,054,000 | -3.2% | 184,892 | +7.7% | 0.07% | +1.5% |
Q2 2022 | $14,512,000 | +7.2% | 171,678 | +11.3% | 0.06% | +14.0% |
Q1 2022 | $13,540,000 | +1290.1% | 154,298 | +1286.0% | 0.06% | +1325.0% |
Q4 2021 | $974,000 | +109.0% | 11,133 | +95.4% | 0.00% | +100.0% |
Q3 2021 | $466,000 | +3.1% | 5,697 | +14.9% | 0.00% | 0.0% |
Q2 2021 | $452,000 | +7.6% | 4,957 | +0.9% | 0.00% | 0.0% |
Q1 2021 | $420,000 | -5.2% | 4,912 | +4.6% | 0.00% | 0.0% |
Q4 2020 | $443,000 | -4.3% | 4,694 | -11.8% | 0.00% | -33.3% |
Q3 2020 | $463,000 | -28.0% | 5,319 | -27.8% | 0.00% | -40.0% |
Q2 2020 | $643,000 | -13.0% | 7,365 | -17.8% | 0.01% | -16.7% |
Q1 2020 | $739,000 | -9.7% | 8,964 | +3.8% | 0.01% | 0.0% |
Q4 2019 | $818,000 | -1.8% | 8,637 | -9.9% | 0.01% | -14.3% |
Q3 2019 | $833,000 | +42.9% | 9,581 | +50.1% | 0.01% | +40.0% |
Q2 2019 | $583,000 | +12.8% | 6,382 | +18.8% | 0.01% | 0.0% |
Q1 2019 | $517,000 | +20.0% | 5,374 | +7.1% | 0.01% | +25.0% |
Q4 2018 | $431,000 | +0.9% | 5,020 | +1.3% | 0.00% | 0.0% |
Q3 2018 | $427,000 | +27.5% | 4,955 | +11.7% | 0.00% | +33.3% |
Q2 2018 | $335,000 | +7.0% | 4,435 | +14.6% | 0.00% | 0.0% |
Q1 2018 | $313,000 | +58.9% | 3,871 | +65.0% | 0.00% | +50.0% |
Q4 2017 | $197,000 | +14.5% | 2,346 | +17.2% | 0.00% | 0.0% |
Q3 2017 | $172,000 | -97.8% | 2,002 | -97.9% | 0.00% | -98.0% |
Q2 2017 | $7,828,000 | +12.9% | 93,777 | +0.5% | 0.10% | +7.7% |
Q1 2017 | $6,931,000 | +16.5% | 93,322 | +14.3% | 0.09% | +4.6% |
Q4 2016 | $5,948,000 | -4.3% | 81,656 | +3.8% | 0.09% | -7.4% |
Q3 2016 | $6,213,000 | -23.4% | 78,691 | -20.0% | 0.09% | -30.9% |
Q2 2016 | $8,112,000 | +18.3% | 98,313 | +3.8% | 0.14% | +13.3% |
Q1 2016 | $6,859,000 | +6.8% | 94,692 | +26.9% | 0.12% | +0.8% |
Q4 2015 | $6,421,000 | -36.6% | 74,632 | -32.3% | 0.12% | +12.3% |
Q3 2015 | $10,134,000 | +48157.1% | 110,242 | +51900.9% | 0.11% | – |
Q2 2015 | $21,000 | – | 212 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |